Search - tctmd.com

Displaying 341 - 360 of 441

Sort: Relevancy | Date

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Daily News

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Shelley Wood

October 16, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Conference News ESC 2017

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

Todd Neale

August 30, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

Todd Neale

August 18, 2017

News Daily News

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

Michael O'Riordan

August 17, 2017

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

One in Four ICD Patients Need Reintervention Within 5 Years

Ashley Lyles

August 04, 2017

Advertisement

Off Script: Welcome to TCT 2017 in the Mile High City

TCTMD’s Top 10 Most Popular Stories for October 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

EVAR Outcomes Equivalent Between Men and Women, Registries Show

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences

FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

One in Four ICD Patients Need Reintervention Within 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content